Stock Analysis
MarshMRSH
P/E 22.58×· 1Y range 19.48–23.73×· top 13% of history
Sector: Financial Services · Industry: Insurance Agents, Brokers & Service
AnalystsHold31 analystsP/E 22.6× sits at the 87th percentile of its 0.7527948893451973-year history.
Cash covers 8% of debt · Q2 2026.
PMP Verdict
High quality, but expensive
Strengths
- Quality92
- Profitability77
Risks
- Valuation52
Excellent business. Weak entry price.
Bull Case
- ✓Piotroski F-Score 7/9 — high earnings quality
- ✓ROE 25.8% — efficient capital deployment
What's happening with MRSH
Profile
Strong moat, earnings quality and profitability.
How is each axis scored?
- Valuation52/100 · Moderate
- P/E vs own history (87th pct)0/25
- FCF yield (5.3%)20/25
- P/S (3.2x)20/25
- EV/EBIT (18.3x)12/25
- Growth61/100 · Moderate
- Revenue CAGR (8.0%)12/25
- Net income CAGR (7.3%)12/25
- EPS CAGR 5Y (8.3%)12/25
- Fwd implied growth (48.1%)25/25
- Profitability77/100 · Strong
- ROIC (13.2%)12/25
- ROE (25.8%)25/25
- Net margin (14.2%)20/25
- Operating margin (21.6%)20/25
- Financial Health53/100 · Moderate
- Altman Z (2.44)18/25
- Current ratio (1.14)12/25
- Interest coverage (7.3x)18/25
- Net cash / debt (D/A 35%)5/25
- Quality92/100 · Strong
- Piotroski F (7/9)22/25
- Beneish M (-2.49)20/25
- FCF conversion (120%)25/25
- Margin stability (σ 2.9%)25/25
- Moat95/100 · Strong
- ROIC >12% years (5/5 yrs)25/25
- Median gross margin (43.9%)20/25
- FCF-positive years (5/5 yrs)25/25
- Worst-year net margin (worst 14.7%)25/25
Risk Flags
- ⚠P/E 22.6× at top 13% of 1-year history
About Marsh
Marsh is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. Show more
The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
Headquarters: NEW YORK, NY · Employees: 55,700 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
52CP/E (TTM)22.6xB
Grade B: FairPrice / TTM EPS (own statements) — vs own hist. history: 19.5x–23.7x · 87th pct
P/FCF16.3xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield5.3%A
Grade A: ValueTTM (OCF − CapEx) / Market Cap — vs own hist. history: 5.0%–6.4% · 12th pct
P/S (TTM)3.22xB
Grade B: FairPrice / TTM Revenue (own statements) — vs own hist. history: 2.8x–3.5x · 70th pct
EV/EBIT18.3xC
Grade C: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own hist. history: 16.0x–18.6x · 98th pct
EV/Sales—
Enterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E15.2xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio5.82xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio2.85C
Grade C: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield1.96%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio44.4%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
77B+ROIC13.2%C
Grade C: AverageNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE25.8%A
Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks
ROA6.8%C
Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin14.2%A
Grade A: HighNet Income / Revenue
Operating Margin21.6%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin43.8%C
Grade C: AverageGross Profit / Revenue
FCF Margin17.1%A
Grade A: HighFCF / Revenue
True FCF Margin15.6%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
61BRevenue CAGR8.0%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR7.3%C
Grade C: OkCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)8.3%C
Grade C: OkCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth48.1%A
Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income10.5%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue1.5%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
53CAltman Z-Score2.44C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.14xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.14xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage7.3xC
Grade C: OkEBIT/Interest. >10 Strong
Debt Repayment4.3yC
Grade C: AverageYears to repay net debt via FCF
Net Debt/EBIT3.4xC
Grade C: MedLeverage. <2x Low, >4x High
Debt/Equity1.45xC
Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.08xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
92A+Piotroski F-Score7/9A
Grade A: StrongFinancial strength 0–9. >7 Strong
Beneish M-Score-2.49A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion119.8%A
Grade A: StrongFCF / Net Income
Margin Stability2.9%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue1.1%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.47xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Brennan Katherine Filed | Brennan Katherine | Option exercise | -1197 | |
Brennan Katherine Filed | Brennan Katherine | SellOpen market sale | -1197 | |
Brennan Katherine Filed | Brennan Katherine | Option exercise | +1.2K | |
Doyle John Q Filed | Doyle John Q | Option exercise | -16656 | |
Doyle John Q Filed | Doyle John Q | SellOpen market sale | -16656 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Doyle John Q Filed | Doyle John Q | Option exercise | +16.7K | |
Lute Jane H Filed | Lute Jane H | Grant / award | +144 | |
Yates Lloyd M Filed | Yates Lloyd M | Grant / award | +224 |
Option exercise (M) rows report a derivative leg, not an open-market sale — a paired negative entry is the option position being consumed.
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
95A+ROIC >12% Years5/5 yrsA
Grade A: DurableShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)43.9%A
Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years5/5 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor14.7%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$8.34
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$3.56
Cash & short-term investments per share (Finnhub)
Book Value / Share$31.77
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$22.38B
Total debt obligations (short + long term)
Cash & Equiv.$1.70B
Cash and short-term investments
Net Debt$20.68B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$15.43B
Shareholders' equity (book value)
Asset / Liability1.35xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$89.88B
Current Market Capitalization
Beta0.56B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Marsh (MRSH)
MRSH is up 0.97% at the last close. Marsh meets 7 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 2.44 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out. Beneish M-Score of -2.49 suggests a low likelihood of earnings manipulation.
- Marsh converts about 17% of revenue into free cash flow — strong cash generation.
- Takes ~4.3 years to repay net debt from free cash flow.
- Return on equity of 25.8% is well above the market average.
See how MRSH ranks on the Capex Tracker — top 50 capital spenders compared.
Earnings
View earnings calendar →Recent Earnings Results
| Date | Time | EPS Est. | EPS Actual | Surprise | Rev Est. | Rev Actual |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Pre-Mkt | $2.01 | — | — | $6.8B | — |
Recent Market Moves
See all MRSH moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 15 | Regular | 186.38 | +4.47% | 4.90 |
| Oct 15 | After-hours | 186.54 | +4.56% | 5.00 |
Frequently Asked Questions about MRSH
What is the current Marsh (MRSH) stock price?
MRSH is trading at $188.35 at the last market close, up 0.97% on the session. PreMarketPrice tracks MRSH pre-market, intraday and after-hours prices.
Is MRSH stock a buy right now?
PreMarketPrice's quantitative model rates Marsh's financial health at 53/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is MRSH stock overvalued?
Marsh trades at a trailing P/E of 22.6 and our valuation score rates it 52/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Marsh report earnings?
No confirmed earnings date is currently scheduled for MRSH. The Earnings section lists recent reports and updates as dates are announced.
What sector does Marsh operate in?
Marsh operates in the Financial Services sector, within the Insurance Agents, Brokers & Service industry. The Related Stocks section lists sector peers for comparison.
What does Marsh do?
Marsh is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital.
About Marsh (MRSH) Stock
Marsh (MRSH) is a US-listed stock operating in the Financial Services sector, specifically the Insurance Agents, Brokers & Service industry. As of the latest update, Marsh is trading at $188.35, up 0.97% on the day with a market capitalization of $89.9 billion. The financial health score for MRSH is 53/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for MRSH stock.
MRSH Stock Analysis & Key Metrics
On PreMarketPrice, you can track Marsh (MRSH) across multiple dimensions:
- Pre-market price & movement: Real-time MRSH stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Earnings calendar: Upcoming and past earnings reports for MRSH, including EPS estimates, actual results, and surprise percentages.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for MRSH with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Marsh across multiple reporting periods.
- Financial health score: A composite score of 53/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for MRSH.
- Sector peers: Compare MRSH against 6 other financial services stocks on key financial metrics.
Is MRSH a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Marsh (MRSH) as an investment. The financial health score of 53/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average. Earnings data reveals whether the company is meeting or beating analyst expectations.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Marsh (MRSH) trades on NYSE. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.